Clinical Trials Logo

Clinical Trial Summary

Participants will be recruited to complete self reported surveys normally used as standards of care for screening and monitoring depression and anxiety symptom severity, provide a voice sample composed of an answer to open ended questions and then be assessed by a mental health professional using structured and clinically validated assessment tools for depression and anxiety. Their voice will be analyzed by machine learning models that predict the severity of depression and anxiety symptoms. The models' performance will be compared to the clinician assessments and how that correlation compares to a similar comparison between the clinician assessments with the self reported surveys. It is hypothesized that the performance of the machine learning models in assessing the severity of depression and anxiety symptoms is no worse than the self reported surveys when both are compared to clinician assessments. It is also hypothesized that presence or absence of the diagnoses of Major Depressive Disorder and Generalized Anxiety Disorder can be predicted better than chance by the analysis of the participant's voice sample using machine learning models.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06464575
Study type Observational
Source Ellipsis Health
Contact
Status Enrolling by invitation
Phase
Start date January 12, 2024
Completion date June 2024

See also
  Status Clinical Trial Phase
Recruiting NCT05866185 - Improving Adherence to Homework During Therapy N/A
Not yet recruiting NCT06377189 - Psychiatric Consultation-Liaison Intervention in Primary Care: A Pilot Study N/A
Recruiting NCT06324864 - START NOW Adapted: Culturally Adapted Version of START NOW N/A
Recruiting NCT06282523 - Healthy Minds Comparison Study N/A
Not yet recruiting NCT06419868 - Acceptability and Feasibility of a Universal Preventive Intervention N/A
Completed NCT02042001 - Switching From Efavirenz/Atripla to Rilpivirine Among Patients With Neurocognitive or Neuropsychological Side Effects Phase 4
Recruiting NCT06318962 - Examining the Efficacy of a Digital Therapeutic to Prevent Suicidal Behaviors N/A
Recruiting NCT06290180 - Healing Lodge First Face Training Evaluation Study N/A